[Translation] A randomized, double-blind, placebo-parallel-controlled, dose-exploring, multi-center, phase IIa clinical trial of Jinghong Granules in the treatment of coronary heart disease angina pectoris (qi deficiency and blood stasis syndrome)
Jinghong Granules Phase IIa Clinical Trial Plan
以安慰剂为对照,初步探索景红颗粒治疗冠心病心绞痛(气虚血瘀证)的有效性及安全性,并探索最佳剂量。
[Translation] Using placebo as a control, we initially explored the effectiveness and safety of Jinghong Granules in treating coronary heart disease angina pectoris (qi deficiency and blood stasis syndrome), and explored the optimal dosage.